These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27390605)

  • 1. Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Januchowski R; Świerczewska M; Sterzyńska K; Wojtowicz K; Nowicki M; Zabel M
    J Cancer; 2016; 7(10):1295-310. PubMed ID: 27390605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Nowacka M; Kaźmierczak D; Andrzejewska M; Rusek D; Brązert M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines.
    Januchowski R; Zawierucha P; Ruciński M; Zabel M
    Oncol Rep; 2014 Nov; 32(5):1981-90. PubMed ID: 25199881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of
    Nowacka M; Ginter-Matuszewska B; Świerczewska M; Sterzyńska K; Nowicki M; Januchowski R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of lumican expression in ovarian cancer drug-resistant cell lines.
    Klejewski A; Sterzyńska K; Wojtowicz K; Świerczewska M; Partyka M; Brązert M; Nowicki M; Zabel M; Januchowski R
    Oncotarget; 2017 Sep; 8(43):74466-74478. PubMed ID: 29088800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
    J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
    Świerczewska M; Sterzyńska K; Wojtowicz K; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027318
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
    Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
    Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines.
    Świerczewska M; Klejewski A; Wojtowicz K; Brązert M; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29027969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Nowicki M; Brązert J; Januchowski R
    J Cancer; 2018; 9(23):4413-4421. PubMed ID: 30519347
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Sterzyńska K; Kaźmierczak D; Klejewski A; Świerczewska M; Wojtowicz K; Nowacka M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines.
    Świerczewska M; Klejewski A; Brązert M; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29649113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
    Januchowski R; Zawierucha P; Ruciński M; Nowicki M; Zabel M
    Biomed Res Int; 2014; 2014():365867. PubMed ID: 24804215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
    Wojtowicz K; Januchowski R; Nowicki M; Zabel M
    Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin.
    Beyer-Sehlmeyer G; Hiddemann W; Wörmann B; Bertram J
    Eur J Cancer; 1999 Nov; 35(12):1735-42. PubMed ID: 10674022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines.
    Klejewski A; Świerczewska M; Zaorska K; Brązert M; Nowicki M; Zabel M; Januchowski R
    Anticancer Res; 2017 Apr; 37(4):1625-1636. PubMed ID: 28373423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.